ondansetron has been researched along with Abnormalities, Cardiovascular in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The potent hERG channel blocking drug ondansetron is used off-label for treatment of nausea and vomiting in early pregnancy." | 3.88 | Ondansetron and teratogenicity in rats: Evidence for a mechanism mediated via embryonic hERG blockade. ( Danielsson, B; Ritchie, HE; Webster, WS, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danielsson, B | 1 |
| Webster, WS | 1 |
| Ritchie, HE | 1 |
1 other study available for ondansetron and Abnormalities, Cardiovascular
| Article | Year |
|---|---|
Ondansetron and teratogenicity in rats: Evidence for a mechanism mediated via embryonic hERG blockade.
Topics: Abnormalities, Drug-Induced; Animals; Antiemetics; Cardiovascular Abnormalities; Embryo, Mammalian; | 2018 |